A detailed history of Virtu Financial LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Virtu Financial LLC holds 46,953 shares of ATAI stock, worth $66,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,953
Holding current value
$66,203
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$1.27 - $2.6 $59,630 - $122,077
46,953 New
46,953 $62,000
Q4 2023

Feb 26, 2024

BUY
$1.04 - $1.55 $30,305 - $45,167
29,140 New
29,140 $41,000
Q2 2023

Jul 27, 2023

BUY
$1.44 - $2.19 $34,032 - $51,758
23,634 New
23,634 $41,000
Q3 2022

Nov 07, 2022

BUY
$3.14 - $4.87 $144,408 - $223,971
45,990 New
45,990 $152,000
Q1 2022

May 17, 2022

SELL
$4.66 - $7.66 $170,416 - $280,126
-36,570 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$6.82 - $17.8 $249,407 - $650,946
36,570 New
36,570 $279,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $234M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.